Almirall, S.A. (OTCMKTS:LBTSF) Short Interest Down 12.5% in January

Almirall, S.A. (OTCMKTS:LBTSFGet Free Report) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 85,600 shares, a drop of 12.5% from the December 31st total of 97,800 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Almirall Stock Performance

Shares of LBTSF stock remained flat at $9.17 during mid-day trading on Monday. The stock has a 50-day moving average price of $9.17 and a two-hundred day moving average price of $9.39. Almirall has a 1-year low of $9.17 and a 1-year high of $9.17.

Almirall Company Profile

(Get Free Report)

Almirall, SA, a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations.

Further Reading

Receive News & Ratings for Almirall Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Almirall and related companies with MarketBeat.com's FREE daily email newsletter.